Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Dose Range and Hemodynamics in Different Age Groups
NCT06009991Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jul 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in general anesthesia (4 arms), sponsored by Tongji Hospital. Primary endpoint: Occurrence of intraoperative hypotension. Started Jul 2023; status: recruiting.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06009991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06009991.